GoodRx Holdings Inc (GDRX) Q2 2024 Earnings Call Highlights: Revenue Growth Amidst Challenges — Oct 9th, 2024

Total Revenue: Increased 6% year over year to $200.6 million. Prescription Transactions Revenue: Grew 7% year over year to $146.7 million. Subscriptions Revenue: Declined 8% to $22 million. Pharma Manufacturer Solutions Revenue: Increased 9% year over year to $26.5 million. Net Income: $6....

High Growth Tech Stocks In The United States To Watch — Oct 2nd, 2024

Over the last 7 days, the market has remained flat, but it is up 34% over the past year with earnings expected to grow by 15% per annum over the next few years. In this context, identifying high growth tech stocks that can capitalize on these favorable conditions is crucial for investors s...

High Growth Tech Stocks In The United States To Watch — Oct 2nd, 2024

Over the last 7 days, the market has remained flat, but it is up 34% over the past year with earnings expected to grow by 15% per annum over the next few years. In this context, identifying high growth tech stocks that can capitalize on these favorable conditions is crucial for investors s...

High Growth Tech Stocks In The United States To Watch — Oct 2nd, 2024

Over the last 7 days, the market has remained flat, but it is up 34% over the past year with earnings expected to grow by 15% per annum over the next few years. In this context, identifying high growth tech stocks that can capitalize on these favorable conditions is crucial for investors s...

GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call — Oct 10th, 2024

SANTA MONICA, Calif., October 10, 2024--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading prescription savings platform in the U.S., today announced it will release its third quarter 2024 financial results before U.S. markets open on Thursday, N...

ELV vs. GDRX: Which Stock Is the Better Value Option? — Oct 8th, 2024

Investors interested in stocks from the Medical Services sector have probably already heard of Elevance Health (ELV) and GoodRx Holdings, Inc. (GDRX). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. There are plenty o...

High Growth Tech Stocks In The United States To Watch — Oct 2nd, 2024

Over the last 7 days, the market has remained flat, but it is up 34% over the past year with earnings expected to grow by 15% per annum over the next few years. In this context, identifying high growth tech stocks that can capitalize on these favorable conditions is crucial for investors s...

GoodRx Holdings Inc (GDRX) Q2 2024 Earnings Call Highlights: Revenue Growth Amidst Challenges — Oct 9th, 2024

Total Revenue: Increased 6% year over year to $200.6 million. Prescription Transactions Revenue: Grew 7% year over year to $146.7 million. Subscriptions Revenue: Declined 8% to $22 million. Pharma Manufacturer Solutions Revenue: Increased 9% year over year to $26.5 million. Net Income: $6....

High Growth Tech Stocks In The United States To Watch — Oct 2nd, 2024

Over the last 7 days, the market has remained flat, but it is up 34% over the past year with earnings expected to grow by 15% per annum over the next few years. In this context, identifying high growth tech stocks that can capitalize on these favorable conditions is crucial for investors s...

GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to Consumers — Oct 16th, 2024

Approved users will now be able to select an Affirm payment plan for select medications directly on the GoodRx platform SAN FRANCISCO, October 16, 2024--(BUSINESS WIRE)--GoodRx (NASDAQ: GDRX), the leading prescription savings platform in the U.S., today announced consumers will soon be ab...

ELV vs. GDRX: Which Stock Is the Better Value Option? — Oct 8th, 2024

Investors interested in stocks from the Medical Services sector have probably already heard of Elevance Health (ELV) and GoodRx Holdings, Inc. (GDRX). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. There are plenty o...

High Growth Tech Stocks In The United States To Watch — Oct 2nd, 2024

Over the last 7 days, the market has remained flat, but it is up 34% over the past year with earnings expected to grow by 15% per annum over the next few years. In this context, identifying high growth tech stocks that can capitalize on these favorable conditions is crucial for investors s...

High Growth Tech Stocks In The United States To Watch — Oct 2nd, 2024

Over the last 7 days, the market has remained flat, but it is up 34% over the past year with earnings expected to grow by 15% per annum over the next few years. In this context, identifying high growth tech stocks that can capitalize on these favorable conditions is crucial for investors s...

GoodRx Announces Lowest Discounted Cash Price at Retail Pharmacy Locations for neffy® (epinephrine nasal spray) — Sep 26th, 2024

neffy is available in pharmacies this week and the lowest discounted cash price at retail pharmacies can be found exclusively at GoodRx neffy is the first and only needle-free treatment for Type I allergic reactions, including anaphylaxis for adults and children who weigh ≥30 kg (66 lbs...

GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call — Oct 10th, 2024

SANTA MONICA, Calif., October 10, 2024--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading prescription savings platform in the U.S., today announced it will release its third quarter 2024 financial results before U.S. markets open on Thursday, N...

GoodRx Holdings Inc (GDRX) Q2 2024 Earnings Call Highlights: Revenue Growth Amidst Challenges — Oct 9th, 2024

Total Revenue: Increased 6% year over year to $200.6 million. Prescription Transactions Revenue: Grew 7% year over year to $146.7 million. Subscriptions Revenue: Declined 8% to $22 million. Pharma Manufacturer Solutions Revenue: Increased 9% year over year to $26.5 million. Net Income: $6....

GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call — Oct 10th, 2024

SANTA MONICA, Calif., October 10, 2024--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading prescription savings platform in the U.S., today announced it will release its third quarter 2024 financial results before U.S. markets open on Thursday, N...

GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call — Oct 10th, 2024

SANTA MONICA, Calif., October 10, 2024--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading prescription savings platform in the U.S., today announced it will release its third quarter 2024 financial results before U.S. markets open on Thursday, N...

ELV vs. GDRX: Which Stock Is the Better Value Option? — Oct 8th, 2024

Investors interested in stocks from the Medical Services sector have probably already heard of Elevance Health (ELV) and GoodRx Holdings, Inc. (GDRX). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. There are plenty o...

GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to Consumers — Oct 16th, 2024

Approved users will now be able to select an Affirm payment plan for select medications directly on the GoodRx platform SAN FRANCISCO, October 16, 2024--(BUSINESS WIRE)--GoodRx (NASDAQ: GDRX), the leading prescription savings platform in the U.S., today announced consumers will soon be ab...

ELV vs. GDRX: Which Stock Is the Better Value Option? — Oct 8th, 2024

Investors interested in stocks from the Medical Services sector have probably already heard of Elevance Health (ELV) and GoodRx Holdings, Inc. (GDRX). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. There are plenty o...

ELV vs. GDRX: Which Stock Is the Better Value Option? — Oct 8th, 2024

Investors interested in stocks from the Medical Services sector have probably already heard of Elevance Health (ELV) and GoodRx Holdings, Inc. (GDRX). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. There are plenty o...

GoodRx Holdings Inc (GDRX) Q2 2024 Earnings Call Highlights: Revenue Growth Amidst Challenges — Oct 9th, 2024

Total Revenue: Increased 6% year over year to $200.6 million. Prescription Transactions Revenue: Grew 7% year over year to $146.7 million. Subscriptions Revenue: Declined 8% to $22 million. Pharma Manufacturer Solutions Revenue: Increased 9% year over year to $26.5 million. Net Income: $6....

GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call — Oct 10th, 2024

SANTA MONICA, Calif., October 10, 2024--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading prescription savings platform in the U.S., today announced it will release its third quarter 2024 financial results before U.S. markets open on Thursday, N...

ELV vs. GDRX: Which Stock Is the Better Value Option? — Oct 8th, 2024

Investors interested in stocks from the Medical Services sector have probably already heard of Elevance Health (ELV) and GoodRx Holdings, Inc. (GDRX). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. There are plenty o...

GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call — Oct 10th, 2024

SANTA MONICA, Calif., October 10, 2024--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading prescription savings platform in the U.S., today announced it will release its third quarter 2024 financial results before U.S. markets open on Thursday, N...

ELV vs. GDRX: Which Stock Is the Better Value Option? — Oct 8th, 2024

Investors interested in stocks from the Medical Services sector have probably already heard of Elevance Health (ELV) and GoodRx Holdings, Inc. (GDRX). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. There are plenty o...

GoodRx Holdings Inc (GDRX) Q2 2024 Earnings Call Highlights: Revenue Growth Amidst Challenges — Oct 9th, 2024

Total Revenue: Increased 6% year over year to $200.6 million. Prescription Transactions Revenue: Grew 7% year over year to $146.7 million. Subscriptions Revenue: Declined 8% to $22 million. Pharma Manufacturer Solutions Revenue: Increased 9% year over year to $26.5 million. Net Income: $6....

GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call — Oct 10th, 2024

SANTA MONICA, Calif., October 10, 2024--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading prescription savings platform in the U.S., today announced it will release its third quarter 2024 financial results before U.S. markets open on Thursday, N...

High Growth Tech Stocks In The United States To Watch — Oct 2nd, 2024

Over the last 7 days, the market has remained flat, but it is up 34% over the past year with earnings expected to grow by 15% per annum over the next few years. In this context, identifying high growth tech stocks that can capitalize on these favorable conditions is crucial for investors s...

GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to Consumers — Oct 16th, 2024

Approved users will now be able to select an Affirm payment plan for select medications directly on the GoodRx platform SAN FRANCISCO, October 16, 2024--(BUSINESS WIRE)--GoodRx (NASDAQ: GDRX), the leading prescription savings platform in the U.S., today announced consumers will soon be ab...

High Growth Tech Stocks In The United States To Watch — Oct 2nd, 2024

Over the last 7 days, the market has remained flat, but it is up 34% over the past year with earnings expected to grow by 15% per annum over the next few years. In this context, identifying high growth tech stocks that can capitalize on these favorable conditions is crucial for investors s...

GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to Consumers — Oct 16th, 2024

Approved users will now be able to select an Affirm payment plan for select medications directly on the GoodRx platform SAN FRANCISCO, October 16, 2024--(BUSINESS WIRE)--GoodRx (NASDAQ: GDRX), the leading prescription savings platform in the U.S., today announced consumers will soon be ab...

GoodRx Holdings Inc (GDRX) Q2 2024 Earnings Call Highlights: Revenue Growth Amidst Challenges — Oct 9th, 2024

Total Revenue: Increased 6% year over year to $200.6 million. Prescription Transactions Revenue: Grew 7% year over year to $146.7 million. Subscriptions Revenue: Declined 8% to $22 million. Pharma Manufacturer Solutions Revenue: Increased 9% year over year to $26.5 million. Net Income: $6....

GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call — Oct 10th, 2024

SANTA MONICA, Calif., October 10, 2024--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading prescription savings platform in the U.S., today announced it will release its third quarter 2024 financial results before U.S. markets open on Thursday, N...

GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to Consumers — Oct 16th, 2024

Approved users will now be able to select an Affirm payment plan for select medications directly on the GoodRx platform SAN FRANCISCO, October 16, 2024--(BUSINESS WIRE)--GoodRx (NASDAQ: GDRX), the leading prescription savings platform in the U.S., today announced consumers will soon be ab...

GoodRx Announces Lowest Discounted Cash Price at Retail Pharmacy Locations for neffy® (epinephrine nasal spray) — Sep 26th, 2024

neffy is available in pharmacies this week and the lowest discounted cash price at retail pharmacies can be found exclusively at GoodRx neffy is the first and only needle-free treatment for Type I allergic reactions, including anaphylaxis for adults and children who weigh ≥30 kg (66 lbs...

GoodRx Holdings Inc (GDRX) Q2 2024 Earnings Call Highlights: Revenue Growth Amidst Challenges — Oct 9th, 2024

Total Revenue: Increased 6% year over year to $200.6 million. Prescription Transactions Revenue: Grew 7% year over year to $146.7 million. Subscriptions Revenue: Declined 8% to $22 million. Pharma Manufacturer Solutions Revenue: Increased 9% year over year to $26.5 million. Net Income: $6....

GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to Consumers — Oct 16th, 2024

Approved users will now be able to select an Affirm payment plan for select medications directly on the GoodRx platform SAN FRANCISCO, October 16, 2024--(BUSINESS WIRE)--GoodRx (NASDAQ: GDRX), the leading prescription savings platform in the U.S., today announced consumers will soon be ab...

GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to Consumers — Oct 16th, 2024

Approved users will now be able to select an Affirm payment plan for select medications directly on the GoodRx platform SAN FRANCISCO, October 16, 2024--(BUSINESS WIRE)--GoodRx (NASDAQ: GDRX), the leading prescription savings platform in the U.S., today announced consumers will soon be ab...

ELV vs. GDRX: Which Stock Is the Better Value Option? — Oct 8th, 2024

Investors interested in stocks from the Medical Services sector have probably already heard of Elevance Health (ELV) and GoodRx Holdings, Inc. (GDRX). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. There are plenty o...

GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to Consumers — Oct 16th, 2024

Approved users will now be able to select an Affirm payment plan for select medications directly on the GoodRx platform SAN FRANCISCO, October 16, 2024--(BUSINESS WIRE)--GoodRx (NASDAQ: GDRX), the leading prescription savings platform in the U.S., today announced consumers will soon be ab...

GoodRx Holdings Inc (GDRX) Q2 2024 Earnings Call Highlights: Revenue Growth Amidst Challenges — Oct 9th, 2024

Total Revenue: Increased 6% year over year to $200.6 million. Prescription Transactions Revenue: Grew 7% year over year to $146.7 million. Subscriptions Revenue: Declined 8% to $22 million. Pharma Manufacturer Solutions Revenue: Increased 9% year over year to $26.5 million. Net Income: $6....

GoodRx Announces Lowest Discounted Cash Price at Retail Pharmacy Locations for neffy® (epinephrine nasal spray) — Sep 26th, 2024

neffy is available in pharmacies this week and the lowest discounted cash price at retail pharmacies can be found exclusively at GoodRx neffy is the first and only needle-free treatment for Type I allergic reactions, including anaphylaxis for adults and children who weigh ≥30 kg (66 lbs...